This inventor holds 1 USPTO granted patent. Top assignees: Pharmacia Corporation, Sugen Incorporated. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 220 
1 out of 157 
Years Active: 2008
Title: Parul Doshi: Innovator in Cancer Treatment
Introduction
Parul Doshi is a notable inventor based in Wildwood, MO (US), recognized for his contributions to cancer treatment through innovative pharmaceutical research. His work primarily focuses on the development of protein kinase inhibitors and cyclooxygenase inhibitors, which are crucial in combination therapies for neoplasia disorders.
Latest Patents
Parul Doshi holds 1 patent for his invention titled "Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer." This patent outlines methods for the treatment or prevention of neoplasia disorders using specific protein tyrosine kinase inhibitors in conjunction with cyclooxygenase inhibitors, particularly those selective for cyclooxygenase-2.
Career Highlights
Throughout his career, Parul has worked with prominent companies in the pharmaceutical industry, including Sugen Incorporated and Pharmacia Corporation. His experience in these organizations has significantly contributed to his expertise in drug development and cancer therapies.
Collaborations
Parul has collaborated with esteemed colleagues such as Jaime L. Masferrer and Julie Cherrington, who have also made significant contributions to the field of cancer research.
Conclusion
Parul Doshi's innovative work in developing cancer treatment therapies showcases his dedication to advancing medical science. His contributions continue to impact the field positively, paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile